Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | HEXA | P06865 | 1/20 | 0.37 |
| ▸ | HEXB | P07686 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21384271 | 0.83 | ALDH1A1 (0.52) | ALDH1A1PKMHEXAHEXBMAPK1 | |
| SCHEMBL10949287 | 0.75 | ALDH1A1 (0.36) | ALDH1A1PKM | |
| SCHEMBL22403740 | 0.70 | ALDH1A1 (0.48) | ALDH1A1PKMHEXAHEXB | |
| SCHEMBL10901592 | 0.67 | ALDH1A1 (0.61) | ALDH1A1PKM | |
| SCHEMBL20880300 | 0.67 | ELANE (0.50) | ALDH1A1MAPK1 | |
| SCHEMBL9563132 | 0.66 | ALDH1A1 (0.54) | ALDH1A1PKMMAPK1 | |
| SCHEMBL22403737 | 0.63 | ALDH1A1 (0.44) | ALDH1A1PKM | |
| SCHEMBL15975535 | 0.63 | ALDH1A1 (0.56) | ALDH1A1PKMMAPK1 | |
| SCHEMBL14377618 | 0.63 | ALDH1A1 (0.56) | ALDH1A1PKMMAPK1MAOB | |
| SCHEMBL11476165 | 0.63 | ALDH1A1 (0.50) | ALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240336599-A1 | PHOTOSENSITIVE POLYAMIC ACID AND DIAZIRINE COMPOSITIONS | PROMERUS, LLC (US) | 2024-10-10 | — | — | US | claimed |
| US-20240336599-A1 | PHOTOSENSITIVE POLYAMIC ACID AND DIAZIRINE COMPOSITIONS | PROMERUS, LLC (US) | 2024-10-10 | — | — | US | disclosed |
| US-11535709-B2 | Reactive end group containing polyimides and polyamic acids and photosensitive compositions thereof | PROMERUS, LLC (US) | 2022-12-27 | — | — | US | disclosed |
| US-20200285151-A1 | PHOTOSENSITIVE POLYIMIDE COMPOSITIONS | PROMERUS, LLC (US) | 2020-09-10 | — | — | US | disclosed |
| US-20200283579-A1 | REACTIVE END GROUP CONTAINING POLYIMIDES AND POLYAMIC ACIDS AND PHOTOSENSITIVE COMPOSITIONS THEREOF | PROMERUS, LLC (US) | 2020-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240336599-A1 | PHOTOSENSITIVE POLYAMIC ACID AND DIAZIRINE COMPOSITIONS | PUF60, FTO, PARN | ALDH1A1 2713/4885PKM 98/4885HEXA 4062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.